Is CELC or ADUS more profitable?

Addus HomeCare has a net margin of 6.89% compared to Celcuity's net margin of 0.00%. Addus HomeCare's return on equity of 9.80% beat Celcuity's return on equity. Company Net Margins Return on Equity Return on Assets Celcuity N/A -244.61% -50.22% Addus HomeCare 6.89% 9.80% 7.34%

Which has stronger earnings and valuation, PACS or ADUS?

PACS Group has higher revenue and earnings than Addus HomeCare. Addus HomeCare is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PACS Group $5.29B 1.11 $191.54M $1.56 23.79 Addus HomeCare $1.42B 1.21 $95.91M $5.41 17.02

Addus HomeCare (ADUS) Competitors

$92.10 +2.40 (+2.68%)

Closing price 06/5/2026 04:00 PM Eastern

Extended Trading

$92.06 -0.04 (-0.05%)

As of 06/5/2026 05:55 PM Eastern

Compare

ADUS vs. CELC, HIMS, PACS, CAI, and BLLN

Should you buy Addus HomeCare stock or one of its competitors? MarketBeat compares Addus HomeCare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Addus HomeCare include Celcuity (CELC), Hims & Hers Health (HIMS), PACS Group (PACS), Caris Life Sciences (CAI), and Billiontoone (BLLN). These companies are all part of the "healthcare" industry.

How does Addus HomeCare compare to Celcuity?

Celcuity (NASDAQ:CELC) and Addus HomeCare (NASDAQ:ADUS) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends.

Addus HomeCare has a net margin of 6.89% compared to Celcuity's net margin of 0.00%. Addus HomeCare's return on equity of 9.80% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
Addus HomeCare	6.89%	9.80%	7.34%

63.3% of Celcuity shares are owned by institutional investors. Comparatively, 95.4% of Addus HomeCare shares are owned by institutional investors. 13.3% of Celcuity shares are owned by insiders. Comparatively, 4.1% of Addus HomeCare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Addus HomeCare has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
Addus HomeCare	$1.42B	1.21	$95.91M	$5.41	17.02

Celcuity has a beta of 0.1, indicating that its stock price is 90% less volatile than the broader market. Comparatively, Addus HomeCare has a beta of 0.89, indicating that its stock price is 11% less volatile than the broader market.

Celcuity presently has a consensus price target of $152.09, indicating a potential upside of 72.28%. Addus HomeCare has a consensus price target of $131.22, indicating a potential upside of 42.48%. Given Celcuity's stronger consensus rating and higher possible upside, equities research analysts clearly believe Celcuity is more favorable than Addus HomeCare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73

In the previous week, Celcuity had 33 more articles in the media than Addus HomeCare. MarketBeat recorded 33 mentions for Celcuity and 0 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.00 beat Celcuity's score of -0.23 indicating that Addus HomeCare is being referred to more favorably in the news media.

Company	Overall Sentiment
Celcuity	Neutral
Addus HomeCare	Neutral

Summary

Addus HomeCare beats Celcuity on 11 of the 16 factors compared between the two stocks.

How does Addus HomeCare compare to Hims & Hers Health?

Addus HomeCare (NASDAQ:ADUS) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment.

In the previous week, Hims & Hers Health had 22 more articles in the media than Addus HomeCare. MarketBeat recorded 22 mentions for Hims & Hers Health and 0 mentions for Addus HomeCare. Hims & Hers Health's average media sentiment score of 0.83 beat Addus HomeCare's score of 0.00 indicating that Hims & Hers Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Addus HomeCare	Neutral
Hims & Hers Health	Positive

Addus HomeCare has a net margin of 6.89% compared to Hims & Hers Health's net margin of -0.56%. Addus HomeCare's return on equity of 9.80% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	6.89%	9.80%	7.34%
Hims & Hers Health	-0.56%	6.10%	1.52%

Hims & Hers Health has higher revenue and earnings than Addus HomeCare. Hims & Hers Health is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.42B	1.21	$95.91M	$5.41	17.02
Hims & Hers Health	$2.35B	2.59	$128.37M	-$0.09	N/A

Addus HomeCare presently has a consensus price target of $131.22, indicating a potential upside of 42.48%. Hims & Hers Health has a consensus price target of $28.70, indicating a potential upside of 9.32%. Given Addus HomeCare's stronger consensus rating and higher possible upside, equities research analysts plainly believe Addus HomeCare is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73
Hims & Hers Health	2 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.12

Addus HomeCare has a beta of 0.89, suggesting that its share price is 11% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.37, suggesting that its share price is 137% more volatile than the broader market.

95.4% of Addus HomeCare shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 4.1% of Addus HomeCare shares are owned by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Addus HomeCare beats Hims & Hers Health on 10 of the 17 factors compared between the two stocks.

How does Addus HomeCare compare to PACS Group?

PACS Group (NYSE:PACS) and Addus HomeCare (NASDAQ:ADUS) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability.

95.4% of Addus HomeCare shares are held by institutional investors. 70.1% of PACS Group shares are held by company insiders. Comparatively, 4.1% of Addus HomeCare shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, PACS Group's average media sentiment score of 0.00 equaled Addus HomeCare'saverage media sentiment score.

Company	Overall Sentiment
PACS Group	Neutral
Addus HomeCare	Neutral

PACS Group presently has a consensus target price of $48.00, suggesting a potential upside of 29.36%. Addus HomeCare has a consensus target price of $131.22, suggesting a potential upside of 42.48%. Given Addus HomeCare's stronger consensus rating and higher probable upside, analysts plainly believe Addus HomeCare is more favorable than PACS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73

Addus HomeCare has a net margin of 6.89% compared to PACS Group's net margin of 4.49%. PACS Group's return on equity of 26.47% beat Addus HomeCare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.49%	26.47%	4.36%
Addus HomeCare	6.89%	9.80%	7.34%

PACS Group has higher revenue and earnings than Addus HomeCare. Addus HomeCare is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.29B	1.11	$191.54M	$1.56	23.79
Addus HomeCare	$1.42B	1.21	$95.91M	$5.41	17.02

Summary

Addus HomeCare beats PACS Group on 9 of the 14 factors compared between the two stocks.

How does Addus HomeCare compare to Caris Life Sciences?

Caris Life Sciences (NASDAQ:CAI) and Addus HomeCare (NASDAQ:ADUS) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk, analyst recommendations and media sentiment.

95.4% of Addus HomeCare shares are owned by institutional investors. 50.0% of Caris Life Sciences shares are owned by insiders. Comparatively, 4.1% of Addus HomeCare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Caris Life Sciences had 2 more articles in the media than Addus HomeCare. MarketBeat recorded 2 mentions for Caris Life Sciences and 0 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.00 beat Caris Life Sciences' score of -0.24 indicating that Addus HomeCare is being referred to more favorably in the news media.

Company	Overall Sentiment
Caris Life Sciences	Neutral
Addus HomeCare	Neutral

Addus HomeCare has a net margin of 6.89% compared to Caris Life Sciences' net margin of 3.75%. Caris Life Sciences' return on equity of 98.28% beat Addus HomeCare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Caris Life Sciences	3.75%	98.28%	48.87%
Addus HomeCare	6.89%	9.80%	7.34%

Addus HomeCare has higher revenue and earnings than Caris Life Sciences. Caris Life Sciences is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Caris Life Sciences	$812.03M	5.74	-$68.09M	-$7.61	N/A
Addus HomeCare	$1.42B	1.21	$95.91M	$5.41	17.02

Caris Life Sciences presently has a consensus price target of $27.56, suggesting a potential upside of 67.10%. Addus HomeCare has a consensus price target of $131.22, suggesting a potential upside of 42.48%. Given Caris Life Sciences' higher probable upside, analysts plainly believe Caris Life Sciences is more favorable than Addus HomeCare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73

Summary

Addus HomeCare beats Caris Life Sciences on 10 of the 16 factors compared between the two stocks.

How does Addus HomeCare compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and Addus HomeCare (NASDAQ:ADUS) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends.

Addus HomeCare has a net margin of 6.89% compared to Billiontoone's net margin of 0.00%. Addus HomeCare's return on equity of 9.80% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	N/A	N/A	N/A
Addus HomeCare	6.89%	9.80%	7.34%

95.4% of Addus HomeCare shares are held by institutional investors. 4.1% of Addus HomeCare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Addus HomeCare has higher revenue and earnings than Billiontoone. Addus HomeCare is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$305.11M	14.65	$7.45M	$0.55	176.71
Addus HomeCare	$1.42B	1.21	$95.91M	$5.41	17.02

In the previous week, Billiontoone had 2 more articles in the media than Addus HomeCare. MarketBeat recorded 2 mentions for Billiontoone and 0 mentions for Addus HomeCare. Billiontoone's average media sentiment score of 1.22 beat Addus HomeCare's score of 0.00 indicating that Billiontoone is being referred to more favorably in the media.

Company	Overall Sentiment
Billiontoone	Positive
Addus HomeCare	Neutral

Billiontoone presently has a consensus target price of $125.29, suggesting a potential upside of 28.91%. Addus HomeCare has a consensus target price of $131.22, suggesting a potential upside of 42.48%. Given Addus HomeCare's stronger consensus rating and higher possible upside, analysts clearly believe Addus HomeCare is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73

Summary

Addus HomeCare beats Billiontoone on 12 of the 16 factors compared between the two stocks.

Get Addus HomeCare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ADUS vs. The Competition

Export

Metric	Addus HomeCare	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.67B	$5.55B	$6.46B	$12.45B
Dividend Yield	N/A	1.59%	2.67%	5.34%
P/E Ratio	17.02	33.34	23.69	23.63
Price / Sales	1.21	25.89	537.82	126.29
Price / Cash	13.81	15.80	42.35	57.17
Price / Book	1.57	3.07	9.73	6.37
Net Income	$95.91M	$218.81M	$3.56B	$337.36M
7 Day Performance	0.46%	-1.51%	-2.92%	-2.39%
1 Month Performance	-4.70%	-2.46%	-0.85%	-0.58%
1 Year Performance	-18.59%	8.44%	22.23%	25.53%

Addus HomeCare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ADUS Addus HomeCare	3.5509 of 5 stars	$92.10 +2.7%	$131.22 +42.5%	-17.9%	$1.67B	$1.42B	17.02	50,659
CELC Celcuity	2.9996 of 5 stars	$94.82 -28.6%	$150.27 +58.5%	+649.4%	$6.48B	N/A	N/A	40	Trending News Analyst Forecast Analyst Revision
HIMS Hims & Hers Health	3.3354 of 5 stars	$27.96 +6.9%	$28.70 +2.6%	-50.3%	$6.43B	$2.37B	N/A	2,442
PACS PACS Group	3.7603 of 5 stars	$35.17 -4.1%	$48.00 +36.5%	+257.9%	$5.80B	$5.43B	22.56	47,455
CAI Caris Life Sciences	4.747 of 5 stars	$16.04 -4.1%	$27.56 +71.8%	N/A	$4.73B	$812.03M	N/A	1,846

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ADUS) was last updated on 6/6/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Addus HomeCare (ADUS) Competitors

ADUS vs. CELC, HIMS, PACS, CAI, and BLLN

How does Addus HomeCare compare to Celcuity?

Summary

How does Addus HomeCare compare to Hims & Hers Health?

Summary

How does Addus HomeCare compare to PACS Group?

Summary

How does Addus HomeCare compare to Caris Life Sciences?

Summary

How does Addus HomeCare compare to Billiontoone?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADUS vs. The Competition

Addus HomeCare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Addus HomeCare (ADUS) Competitors

ADUS vs. CELC, HIMS, PACS, CAI, and BLLN

How does Addus HomeCare compare to Celcuity?

Is CELC or ADUS more profitable?

Do insiders and institutionals believe in CELC or ADUS?

Which has better valuation & earnings, CELC or ADUS?

Which has more volatility & risk, CELC or ADUS?

Do analysts recommend CELC or ADUS?

Does the media prefer CELC or ADUS?

Summary

How does Addus HomeCare compare to Hims & Hers Health?

Does the media refer more to ADUS or HIMS?

Is ADUS or HIMS more profitable?

Which has higher earnings and valuation, ADUS or HIMS?

Do analysts rate ADUS or HIMS?

Which has more volatility & risk, ADUS or HIMS?

Do institutionals and insiders have more ownership in ADUS or HIMS?

Summary

How does Addus HomeCare compare to PACS Group?

Do insiders and institutionals hold more shares of PACS or ADUS?

Does the media prefer PACS or ADUS?

Do analysts recommend PACS or ADUS?

Is PACS or ADUS more profitable?

Which has stronger earnings and valuation, PACS or ADUS?

Summary

How does Addus HomeCare compare to Caris Life Sciences?

Do insiders & institutionals have more ownership in CAI or ADUS?

Does the media refer more to CAI or ADUS?

Is CAI or ADUS more profitable?

Which has stronger valuation & earnings, CAI or ADUS?

Do analysts rate CAI or ADUS?

Summary

How does Addus HomeCare compare to Billiontoone?

Is BLLN or ADUS more profitable?

Do institutionals and insiders hold more shares of BLLN or ADUS?

Which has higher earnings & valuation, BLLN or ADUS?

Does the media refer more to BLLN or ADUS?

Do analysts recommend BLLN or ADUS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADUS vs. The Competition

Addus HomeCare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools